twenty-seven patients with cystic fibrosis completed a controlled trial comparing the effects of an inhaled mucolytic drug , sodium-2-mercaptoethane sulphonate ( mistabron , ucb pharmaceutical division , brussels , belgium ) , with inhaled iso-osmolar hypertonic saline .
C0000294
sodium-2-mercaptoethane
C0733874
mistabron